CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products

CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products

Adoptive cellular immunotherapy with chimeric antigen receptor (CAR) T cell has changed the treatment landscape of B-cell non-Hodgkin’s lymphoma (NHL), especially for aggressive B-cell lymphomas. Single-center and multicenter clinical trials with anti-CD19 CAR T-cell therapy have shown great activit...

Full description

Bibliographic Details
Main Authors: Julio C. Chavez, Christina Bachmeier, Mohamed A. Kharfan-Dabaja
Format: Article
Language:English
Published: SAGE Publishing 2019-04-01
Series:Therapeutic Advances in Hematology
Online Access:https://doi.org/10.1177/2040620719841581

Similar Items

Similar Items